This powerful treatment brightens skin, supports detoxification, strengthens immunity, and restores a healthy, even-toned glow that radiates vitality from within
The published clinical data - 19.5% average body weight reduction at 52 weeks across 1,131 patients, published in a peer-reviewed journal (this outcome reflects a retrospective analysis of program completers and should not be interpreted as typical or guaranteed) - is a published peer-reviewed evidence base, which is uncommon among telehealth GLP-1 platforms
Popular GLP-1 Medications and Peptide Therapies Common therapies include: Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Other peptides, like Sermorelin and BPC-157 , are used in regenerative medicine for performance, recovery, and longevity
All major medications Ozempic, Mounjaro, and Wegovy are approved in Japan, though primarily for diabetes management rather than weight loss